[MMA News Now, Jan. 2, 2014]
Prescribers of extended-release (ER) and long-acting (LA) opioid medications should plan to attend a free seminar on opioid prescribing from 8:30 a.m. to 1 p.m. on Feb. 8 at the University of Minnesota's McNamara Alumni Center.
On July 9, 2012, the Food and Drug Administration (FDA) approved a risk evaluation and mitigation strategy (REMS) for ER and LA opioid medications. The Collaborative on REMS Education (CO*RE), a multidisciplinary collaboration of 10 partners and three cooperating organizations, has designed a core curriculum based on needs assessment, practice gaps, clinical competencies, learner self-assessment, with shared tools, resources and outcomes to meet the requirements of the FDA REMS blueprint.
The event will feature Gavin Bart, M.D., director of the division of addiction medicine at Hennepin County Medical Center and associate professor of medicine at the University of Minnesota; and Charlie Reznikoff, M.D., an addiction medicine and internal medicine doctor, who works in the division of addiction medicine and is an assistant professor of medicine at the University of Minnesota.
The Minnesota Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live activity for a maximum of 4
AMA PRA Category 1 Credit(s)
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
to register. The event includes a brunch for participants.